The Business Times

Medical drugs

Opinion & Features

The Pfizer-Trump deal: A new chapter in drug pricing or political theatre?

Earlier this week, Trump linked Tylenol – the most popular brand of acetaminophen in the US – to autism and urged pregnant women to avoid the common painkiller.
Singapore

HSA refutes Trump claim linking paracetamol and autism

epa12400025 Tylenol, a brand of medication with active ingredient of paracetamol, pictured in New York, New York, USA, 23 September 2025. US President Trump has linked the use of the painkiller paracetamol during pregnancy to autism during an event at the White House in Washington, DC on 22 September 2025. EPA/JOHN TAGGART ILLUSTRATION
Opinion & Features

The US president is wrong on Tylenol

The government’s ‘Made in China 2025’ plan to elevate manufacturing in 10 priority sectors also helped spur a flurry of investments in biotechnology.
Global Enterprise

China biotech’s stunning advance is changing the world’s drug pipeline

WeightWatchers says the restructuring plan will “significantly reduce” its debt obligations.
Consumer & Healthcare

WeightWatchers files bankruptcy as GLP-1 drugs reshape market

China’s retaliatory tariff against US imports is already taking a toll on hospitals and drugmakers.
International

China asks drugmakers, hospitals to find US import substitutes

FILE PHOTO: U.S. dollar banknote and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
Consumer & Healthcare

US pharma tariffs would raise US drug costs by US$51 billion annually, report finds

Richard Saynor, chief executive officer of Sandoz Group AG, speaks during the Sandoz Group AG listing ceremony at the Six Swiss Exchange AG in Zurich, Switzerland, on Wednesday, Oct. 4, 2023. Sandoz, the maker of copycat medicines that was spun off from drugmaker Novartis AG, begins life as a standalone company on Wednesday when its shares start trading on the Swiss stock exchange. Photographer: Pascal Mora/Bloomberg
International

US tariffs will raise drug prices for patients, Sandoz CEO says

Blackstone’s deal for CMIC is the second by a major global private equity firm in the past month in Japan’s pharmaceutical sector.
Companies & Markets

Blackstone buys Japan drug trial firm, adding to private equity health deals

Hand-drawn signs in a school in the US. A serious drive to counter drug abuse needs to prioritise tackling demand.
Opinion & Features

Tariffs and the US’ fentanyl problem

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More